Potentiation of paclitaxel cytotoxicity by inostamycin in human small cell lung carcinoma, Ms-1 cells

Japanese Journal of Cancer Research

Volumn 89, Issue 9, 1998, Pages 970-976

  Simizu, Siro ^a   Tanabe, Keiko ^a   Tashiro, Etsu ^a   Takada, Minoru ^b   Umezawa, Kazuo ^a   Imoto, Masaya ^a  

^a KEIO UNIVERSITY   (Japan)

^b Department of Cardiology   (Japan)

Author keywords

Apoptosis; Caspase 3; Inostamycin; Paclitaxel; Small cell lung carcinoma

Indexed keywords

4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; CAMPTOTHECIN; CISPLATIN; CYSTEINE PROTEINASE; DOXORUBICIN; ETOPOSIDE; INOSTAMYCIN; METHOTREXATE; PACLITAXEL; PROTEIN BAX; PROTEIN BCL 2; TUBULIN; VINBLASTINE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE G1 PHASE; CONTROLLED STUDY; DEPOLYMERIZATION; DOSE RESPONSE; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0031734022     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1998.tb00656.x     Document Type: Article

References (27)

1. Smyth, J. F., Fowlie, S. M., Gregor, A., Crompton, G. K., Busutill, A., Leonard, R. C. F. and Grant, I. W. B. The impact of chemotherapy on small cell carcinoma of bronchus. Q. J. Med., 61, 969-976 (1986).
2. Levitski, A. and Gazit, A. Tyrosine kinase inhibition; an approach to drug development. Science, 267, 1782-1788 (1995).
3. Rowinsky, E. K., Cazenave, L. A. and Donehower, R. C. Taxol: a novel investigational antimicrotubule agent. J. Natl. Cancer Inst., 82, 1247-1259 (1990).
4. Gelmon, K. A. Biweekly paclitaxel (taxol) and cisplatin in breast and ovarian cancer. Semin. Oncol., 21, 24-28 (1994).
5. Parness, J. and Horwitz, S. B. Taxol binds to polymerized tubulin in vitro. J. Cell Biol., 91, 479-487 (1981).
6. Horwitz, S. B. Mechanism of action of Taxol. Trends Pharmacol. Sci., 13, 134-136 (1992).
7. Reed, J. C. Bcl-2 and the regulation of programmed cell death. J. Cell Biol., 124, 1-6 (1994).
8. Boise, L., Gonzalez-Garcia, M., Postema, C., Ding, L., Lindsten, T., Turka, L., Mao, X., Nunez, G. and Thompson, C. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell, 74, 597-608 (1993).
9. Oltvai, Z. N., Milliman, C. L. and Korsmeyer, S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death. Cell, 74, 609-619 (1993).
10. Alnemri, E. S., Livingston, D., Nicholson, D. W., Salvesen, G., Thornberry, N. A., Wong, W. W. and Yuan, J. Human ICE/CED-3 protease nomenclature. Cell, 87, 171 (1996).
11. Chen, Z., Naito, M., Mashima, T. and Tsuruo, T. Activation of actin-cleavable interleukin 1β-converting enzyme (ICE) family protease CPP-32 during chemotherapeutic agent-induced apoptosis in ovarian carcinoma cells. Cancer Res., 56, 5224-5229 (1996).
12. Nicholson, D. W. ICE/CED3-like proteases as therapeutic targets for the control of inappropriate apoptosis. Nat. Biotechnol., 14, 297-301 (1996).
13. Imoto, M., Umezawa, K., Takahashi, Y., Naganawa, H., Iitaka, Y., Nakamura, H., Koizumi, Y., Sasaki, Y., Hamada, M., Sawa, T. and Takeuchi, T. Isolation and structure determination of inostamycin, a novel inhibitor of phosphatidylinositol turnover. J. Nat. Prod., 53, 825-829 (1990).
14. Imoto, M., Taniguchi, Y. and Umezawa, K. Inhibition of CDP-DG:inositol transferase by inostamycin. J. Biochem., 112, 299-302 (1992).
15. Imoto, M., Morii, T., Deguchi, A. and Umezawa, K. Involvement of phosphatidylinositol synthesis in the regulation of S phase induction. Exp. Cell Res., 215, 228-233 (1994).
16. Deguchi, A., Imoto, M. and Umezawa, K. Inhibition of G1 cyclin expression in normal rat kidney cells by inostamycin, a phosphatidylinositol synthesis inhibitor. J. Biochem., 120, 1118-1122 (1996).
17. Kudoh, S., Takada, M., Masuda, N., Nakagawa, K., Itoh, K., Kusunoki, Y., Negoro, S., Matsui, K., Takifuji, N., Morino, H. and Fukuoka, M. Enhanced antitumor efficacy of a combination of CPT-11, a new derivative of camptothecin, and cisplatin against human lung tumor xenografts. Jpn. J. Cancer Res., 84, 203-207 (1993).
18. Tamura, K., Takada, M., Kawase, I., Tada, T., Kudoh, S., Okishio, K., Fukuoka, M., Yamaoka, N., Fujiwara, Y. and Yamakido, M. Enhancement of tumor radio-response by irinotecan in human lung tumor xenografts. Jpn. J. Cancer Res., 88, 218-223 (1997).
19. KIP1 protein in human esophageal cancer cell lines that over-express cyclin D1. Carcinogenesis, 18, 1139-1148 (1997).
20. Haldar, A., Basu, A. and Croce, C. M. Bcl2 is the guardian of microtubule integrity. Cancer Res., 57, 229-233 (1997).
21. Haldar, A., Chintapalli, J. and Croce, C. M. Taxol-induced bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res., 56, 1253-1255 (1996).
22. Imoto, M., Tanabe, K., Simizu, S., Tashiro, E., Takada, M. and Umezawa, K. Inhibition of cyclin D1 expression and induction of apoptosis by inostamycin in small cell lung carcinoma cells. Jpn. J. Cancer Res., 89, 315-322 (1998).
23. Kawada, M. and Umezawa, K. Long-lasting accumulation of vinblastine in inostamycin-treated multidrug-resistant KB cells. Jpn. J. Cancer Res., 82, 1160-1164 (1991).
24. Yusa, K. and Tsuruo. T. Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells. Cancer Res., 49, 5002-5006 (1989).
25. Haldar, S., Jena, N. and Croce, C. M. Inactivation of bcl-2 by phosphorylation. Proc. Natl. Acad. Sci. USA, 92, 4507-4511 (1995).
26. Shimizu, S., Eguchi, Y., Kamiike, W., Matsuda, H. and Tsujimoto, Y. Bcl-2 expression prevents activation of the ICE protease cascade. Oncogene, 12, 2251-2257 (1995).
27. L inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells. Cancer Res., 56, 4743-4748 (1996).